How does metformin affect mitochondrial energy production and how do cells survive?

Metformin primarily inhibits mitochondrial energy production by affecting Complex I of the electron transport chain, which is crucial for ATP generation within mitochondria. This inhibition leads to a decrease in ATP production, however, the extent of this inhibition is generally mild to moderate. Cells still survive because they have adaptive mechanisms to manage energy stress. In response to reduced mitochondrial function, cells can increase glycolysis, which is a pathway that doesn’t rely on mitochondria for ATP production. This shift towards glycolytic energy production, often referred to as the Warburg effect in the case of cancer cells, helps maintain energy balance even when mitochondrial output is hampered. Additionally, metformin activates AMP-activated protein kinase (AMPK), a critical energy sensor in the cell. AMPK activation helps promote catabolic pathways that generate ATP and inhibits anabolic pathways that consume ATP, thereby conserving energy. This regulatory role also promotes improved insulin sensitivity and has anti-inflammatory effects, contributing to its widespread use in type 2 diabetes management. Moreover, normal cells have reserve capacity and can adapt their metabolic flexibility to ensure survival under various environmental stresses, while the body’s overall metabolic homeostasis supports this adaptative response. Through these means, cells are able to cope despite the inhibition of mitochondrial energy production.